Surprisingly Low Levels of Measles Immunity in Persons With HIV: A Seroprevalence Survey in a United States HIV Clinic
Open Access
- 12 September 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 7 (10)
Abstract
Background: Measles outbreaks have become increasingly common due to deteriorating vaccination rates, fluctuating herd immunity, and varying antibody decline. Limited knowledge exists regarding prevalence and risk factors associated with measles seronegativity among persons with HIV (PWH). Methods: This was a cross-sectional study conducted at an academic HIV clinic in Omaha, Nebraska. Participants were screened for the presence of measles IgG antibody. Demographic and clinical information was obtained through electronic medical record review. Simple and multivariable logistic regressions were performed to identify risk factors for measles seronegativity. Results: Three hundred fifty-one participants were enrolled, with a measles seroprevalence rate of 70.3%. The mean age (range) was 48 (20–74) years, 77% were male, and 53% were Caucasian. The mean CD4 nadir (range) was 334 (1–1675) cells/mm3. At the time of testing, 86% and 87% of the seronegative and seropositive participants had an HIV RNA <50 copies/mL, respectively. Younger age was significantly associated with measles seronegativity (P = .003), as was birth year after 1957 (P = .021). Prior history of measles infection was associated with seropositivity (P = .011). All other risk factors evaluated, including written documentation of adequate vaccination, were not associated with seronegativity. Conclusions: Our study demonstrates a measles seroprevalence rate that is remarkably lower than previously reported in PWH (92%), and, more importantly, is considerably lower than the rate needed to maintain herd immunity (95%). With higher than expected seronegativity and absence of notable risk factors aside from age, our findings support expanded measles immunity screening for PWH who are at risk of measles exposure.Keywords
Funding Information
- Nebraska Medicine
- University of Nebraska Medical Center (MXH/99-925-1447)
This publication has 26 references indexed in Scilit:
- Who Gets Measles in Europe?The Journal of Infectious Diseases, 2011
- Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adultsVaccine, 2011
- Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAARTVaccine, 2009
- Evaluation of the Immune Response to a 2‐Dose Measles Vaccination Schedule Administered at 6 and 9 Months of Age to HIV‐Infected and HIV‐Uninfected Children in MalawiThe Journal of Infectious Diseases, 2008
- Immunogenicity of Standard‐Titer Measles Vaccine in HIV‐1–Infected and Uninfected Zambian Children: An Observational StudyThe Journal of Infectious Diseases, 2007
- Measles seroprevalence and vaccine response in HIV-infected adultsVaccine, 1994
- Subacute Measles Encephalitis in the Young Immunocompromised Host: Report of Two Cases Diagnosed by Polymerase Chain Reaction and Treated with Ribavirin and Review of the LiteratureClinical Infectious Diseases, 1993
- Prevalence of measles antibodies in adults with HIV infectionAIDS, 1992
- Prevalence of Measles Antibodies in Asymptomatic Human Immunodeficiency Virus-Infected AdultsThe Journal of Infectious Diseases, 1991
- Fatal Measles Pneumonia Without Rash in a Child with AIDSThe Journal of Infectious Diseases, 1988